• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The validity of clinical practice guidelines for empirical use of oseltamivir for influenza in Thai children

tetano

Editor, Senior Moderator
Paediatr Int Child Health. 2015 Aug 20:2046905515Y0000000052. [Epub ahead of print]
[h=1]The validity of clinical practice guidelines for empirical use of oseltamivir for influenza in Thai children.[/h] Wongsawat J, Chittaganpitch M, Aumpornareekul S, Srisopa S, Likanonsakul S.
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Clinical practice guidelines for influenza have been implemented to maximise the appropriate use of empirical oseltamivir; however, good predictive values are required.
[h=4]METHODS:[/h] Between October 2011 and September 2013, children aged < 15 years who presented at the Bamrasnaradura Infectious Diseases Institute with an influenza-like illness plus either (i) pneumonia or (ii) being in a higher risk group for influenza complications were prospectively enrolled. Respiratory specimens were taken for real-time polymerase chain reaction testing (RT-PCR). Clinical characteristics, laboratory data and oseltamivir therapy were recorded.
[h=4]RESULTS:[/h] 85 cases were enrolled. Of these, the proportions of those with pneumonia, who were aged < 2 years and who had underlying diseases were 74.1%, 56.5% and 38.8%, respectively. RT-PCR detected respiratory syncytial virus (35.3%), influenza (22.3%), adenovirus (14.1%), human metapneumovirus (5.9%), para-influenza (3.5%) and no viruses (25.9 %). Pneumonia (OR 0.16, 95% CI 0.05-0.50) and having two clinical criteria (OR 0.24, 95% CI 0.08-0.76) were significantly negative predictors for influenza. Having cluster transmissions (OR 5.18, 95% CI 1.38-19.37) and a monocyte proportion >7% (OR 3.58, 95% CI 1.15-11.17) were significantly positive predictors of influenza. The mean (SD) percentage of influenza-like illness during the study period was 7.04 (2.02).
[h=4]CONCLUSIONS:[/h] Clinical criteria guidelines yielded a low predictive value (22.3%) for influenza among children. Seasonality, cluster transmission, white blood cell and differential counts may be helpful in diagnosing influenza. Nonetheless, empirical oseltamivir should not be delayed for those in need.


[h=4]KEYWORDS:[/h] Empirical oseltamivir; Higher risk groups for influenza complications,; Lower respiratory tract viral infections,; Pneumonia,

PMID: 26293663 [PubMed - as supplied by publisher]
 
Back
Top Bottom